Skip to main content
Premium Trial:

Request an Annual Quote

Biognosys, Siemens Healthineers Partner for Protein Biomarker Development

NEW YORK — Biognosy said on Tuesday that it has entered a strategic agreement with Siemens Healthineers for the discovery and development of protein biomarkers.

Under the agreement, the firms will use Schlieren, Switzerland-based Biognosys' mass spectrometry technology to discover novel biomarkers, which they will then validate for potential clinical applications including clinical trials and in vitro diagnostics.

The companies will run the project out of Siemens Healthineers' clinical laboratory in Berkeley, California.

"With this agreement we can enable our biopharmaceutical customers to use the power of our proprietary discovery proteomics solution for novel biomarker identification and bring these biomarkers into clinical applications with Siemens Healthineers’ diagnostic assay development expertise," Oliver Rinner, Biognosys' founder and CEO, said in a statement.

"We are excited about this relationship with Biognosys because their expertise and unique biomarker discovery capabilities are very complementary to our end-to-end diagnostic solutions for our biopharmaceutical customers," said Sebastian Kronmueller, head of the Siemens Healthcare Laboratory in California.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.